The speaker is actively shorting the stock, believing its drug was rejected by European regulators ('it's over'). He views its recent price strength as a temporary short-covering rally that will be followed by a 'nice drop'.

The speaker held a major short position, believing a negative EMA decision was imminent. This thesis was confirmed with a 'negative trend vote,' causing the stock to drop significantly. The ultimate belief is the stock will fall to its 'cash' value.

The view is complex and sarcastic; the speaker calls it a 'scam' but also expresses regret for not going long on a past run-up, indicating a neutral/conflicted current stance.

Extremely bearish view, calling it the 'Scam of X' and 'one of the worst drug companies ever,' claiming its drug is 'not real' and will not get approval.

The speaker expressed a highly negative view, referring to the company as 'garbage' and anticipating a rejection from the EMA, stating a recent press release contained 'no new data'.

The speaker explicitly stated they have a short position on the stock, indicating a strong bearish conviction that its value is likely to decrease.

The host is extremely bearish, calling it a 'scam company, scam drug' and implying its failure is a certainty.

The speaker explicitly identifies the stock as a short position, indicating a bearish stance.

The speaker is short the stock and is confident the position will become a big profit, expressing strong conviction in its eventual decline.

Very bearish view; the speaker believes the company is likely to issue new shares, and described the case for shorting the stock as 'conclusive.'